Morgenesis

Morgenesis was established last year. The company aims to streamline all existing POCare service business units into a unified entity, providing treatment developers with comprehensive solutions for producing therapies at the point of care. Morgenesis offers solutions ranging from initial process development, regulatory strategy and implementation, full cGMP processing, and delivery of therapeutic products to patients at the point of care, to clinical trial design and management. It further supports comprehensive cGMP process development, including enabling closed and automated point-of-care treatment processes through Orgenesis' Mobile Processing Units and Labs ("OMPULs").